What made the episode significant was not its novelty — antibiotic shortages have been recurring across Europe for...
Japan-based startup Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, a colla...
Japanese pharma firm Eisai Co. has announced a strategic investment supported by the UK Government under the Life Scienc...
Inflammatory bowel disease is becoming a growing focus within immunology innovation across Asia-Pacific, as the region s...
China-based Simcere Pharmaceutical Group has entered into a research collaboration agreement with Stanford Medicine, US ...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with South Korea's Samil Pharmace...
Korea-based Dong-A ST has entered into an exclusive licensing agreement with Melbourne-based Arrotex Pharmaceuticals, fo...
DFE Pharma, a global leader in pharmaceutical excipients, has earned its third consecutive Gold Medal from EcoVadis, the...
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation, a global biopharmaceutical innovator based i...
Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...
Shionogi has received US FDA approval for XOCOVA, or ensitrelvir, as an oral post-exposure prophylaxis option for COVID-...
Eli Lilly has reported detailed Phase III results from three ACHIEVE trials evaluating Foundayo, or orforglipron, an ora...
VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...
Japan-based GNI Group Co. has entered into an agreement to acquire 100% of the shares of Ayumi Pharmaceutical Holdings C...
China-based Everest Medicines has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co., ...
Genentech has received US FDA approval for Tecentriq and Tecentriq Hybreza as adjuvant treatment for adults with muscle-...
Otsuka has reported positive interim Phase III VISIONARY data showing that VOYXACT preserved kidney function over 12 mon...
Iovance Biotherapeutics, Inc., a US-based biotechnology company focused on innovating, developing, and delivering novel ...
Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...
Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...
AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...
As biologics manufacturing continues to evolve, Asia Pacific is emerging as a key region for innovation in process inten...
Chime Biologics, a China-based biologics CDMO dedicated to enabling partners’ success, and South Korea-based Daewo...
Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...
Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...
